Follow
John Woolcott
John Woolcott
University of British Columbia, Pfizer
Verified email at pfizer.com
Title
Cited by
Cited by
Year
Meta-analysis of the impact of 9 medication classes on falls in elderly persons
JC Woolcott, KJ Richardson, MO Wiens, B Patel, J Marin, KM Khan, ...
Archives of internal medicine 169 (21), 1952-1960, 2009
15532009
A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis
CA Marra, JC Woolcott, JA Kopec, K Shojania, R Offer, JE Brazier, ...
Social science & medicine 60 (7), 1571-1582, 2005
4742005
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real …
P Mease, C Charles-Schoeman, S Cohen, L Fallon, J Woolcott, H Yun, ...
Annals of the rheumatic diseases 79 (11), 1400-1413, 2020
1612020
Does physical activity reduce seniors' need for healthcare?: a study of 24 281 Canadians
JC Woolcott, MC Ashe, WC Miller, P Shi, CA Marra, ...
British Journal of Sports Medicine 44 (12), 902-904, 2010
702010
Characteristics and outcomes of IBD patients with COVID-19 on tofacitinib therapy in the SECURE-IBD registry
M Agrawal, EJ Brenner, X Zhang, I Modesto, J Woolcott, RC Ungaro, ...
Inflammatory bowel diseases 27 (4), 585-589, 2021
622021
Lowering generic drug prices: less regulation equals more competition
AH Anis, DP Guh, J Woolcott
Medical care 41 (1), 135-141, 2003
552003
The cost of fall related presentations to the ED: a prospective, in-person, patient-tracking analysis of health resource utilization
JC Woolcott, KM Khan, S Mitrovic, AH Anis, CA Marra
Osteoporosis international 23, 1513-1519, 2012
442012
Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada
DM Skowronski, JC Woolcott, SA Tweed, RC Brunham, F Marra
Vaccine 24 (19), 4222-4232, 2006
402006
Persistence of tofacitinib in the treatment of rheumatoid arthritis in open‐label, long‐term extension studies up to 9.5 years
JE Pope, E Keystone, S Jamal, L Wang, L Fallon, J Woolcott, I Lazariciu, ...
ACR Open Rheumatology 1 (2), 73-82, 2019
32*2019
The risk of venous thromboembolic events in patients with RA aged≥ 50 years with≥ 1 cardiovascular risk factor: results from a phase 3b/4 randomized safety study of …
C Charles-Schoeman, R Fleischmann, E Mysler, M Greenwald, C Wang, ...
Arthritis & rheumatology 73, 4064-4067, 2021
31*2021
Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis—Patients’ and Physicians’ View
MC Dubinsky, K Watanabe, P Molander, L Peyrin-Biroulet, M Rubin, ...
Inflammatory bowel diseases 27 (11), 1747-1755, 2021
282021
Cost‐utility analysis of a multidisciplinary strategy to manage osteoarthritis of the knee: Economic evaluation of a cluster randomized controlled trial study
CA Marra, M Grubisic, J Cibere, KA Grindrod, JC Woolcott, L Gastonguay, ...
Arthritis Care & Research 66 (6), 810-816, 2014
272014
Longterm drug survival of tumor necrosis factor inhibitors in patients with rheumatoid arthritis
P Emery, B Vlahos, P Szczypa, M Thakur, HE Jones, J Woolcott, ...
The Journal of Rheumatology 47 (4), 493-501, 2020
242020
Safety and cost benefit of same-day discharge after percutaneous coronary intervention
S Khatri, JG Webb, RG Carere, A Amis, J Woolcott, S Chugh, ...
American Journal of Cardiology 90 (4), 425-427, 2002
232002
Ulcerative colitis narrative global survey findings: communication gaps and agreements between patients and physicians
DT Rubin, A Hart, R Panaccione, A Armuzzi, U Suvanto, JJ Deuring, ...
Inflammatory bowel diseases 27 (7), 1096-1106, 2021
222021
Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 years
J Pope, L Bessette, N Jones, L Fallon, J Woolcott, D Gruben, M Crooks, ...
Rheumatology 59 (3), 568-574, 2020
212020
Treatment mode preferences in rheumatoid arthritis: moving toward shared decision-making
PC Taylor, N Betteridge, TM Brown, J Woolcott, AJ Kivitz, C Zerbini, ...
Patient preference and adherence, 119-131, 2020
212020
A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophy
AH Anis, H Sun, S Singh, J Woolcott, B Nosyk, M Brisson
Pharmacoeconomics 24, 387-400, 2006
212006
Predictors of sustained response with tofacitinib therapy in patients with ulcerative colitis
WJ Sandborn, A Armuzzi, G Liguori, PM Irving, AI Sharara, R Mundayat, ...
Inflammatory Bowel Diseases 28 (9), 1338-1347, 2022
162022
Real-world experience with tofacitinib versus adalimumab and etanercept in biologic-naive patients with RA previously treated with methotrexate: data from a US administrative …
T Smith, J Harnett, D Gruben, C Chen, E Agarwal, J Woolcott
ARTHRITIS & RHEUMATOLOGY 69, 2017
152017
The system can't perform the operation now. Try again later.
Articles 1–20